Loading...

AnaptysBio, Inc.

ANAB•NASDAQ
Healthcare
Biotechnology
$66.76
$1.03(1.57%)
U.S. Market opens in 6h 22m

AnaptysBio, Inc. (ANAB) Stock Overview

Explore AnaptysBio, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.9B
P/E Ratio-140.39
EPS (TTM)$-0.46
ROE18.14%
Fundamental Analysis

AI Price Forecasts

1 Month$56.78
3 Months$54.27
1 Year Target$38.50

ANAB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AnaptysBio, Inc. (ANAB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $38.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -140.39 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.57%
5-Day Change
27.55%
1-Month Change
76.57%
3-Month Change
111.20%
6-Month Change
173.72%
Year-to-Date (YTD) Change
106.56%
1-Year Change
361.37%
3-Year Change
373.14%
5-Year Change
322.80%
All-Time (Max) Change
489.23%

Contact Information

https://www.anaptysbio.com
858 362 6295
10770 Wateridge Circle, San Diego, CA, 92121-5801

Company Facts

136 Employees
IPO DateJan 26, 2017
CountryUS
Actively Trading

Frequently Asked Questions